tetano
Editor, Senior Moderator
Am J Otolaryngol
. 2023 Jun 21;44(5):103962.
doi: 10.1016/j.amjoto.2023.103962. Online ahead of print. Olfactory dysfunction incidence and resolution amongst 608 patients with COVID-19 infection
Shannon S Wu[SUP] 1 [/SUP], Claudia I Cabrera[SUP] 2 [/SUP], Humzah A Quereshy[SUP] 2 [/SUP], Arminé Kocharyan[SUP] 3 [/SUP], Brian D'Anza[SUP] 2 [/SUP], Todd Otteson[SUP] 4 [/SUP]
Affiliations
Purpose: Olfactory dysfunction (OD) is a common presenting sign of coronavirus-19 (COVID-19) infection and remains persistent in up to 7 % of patients one year after diagnosis. However, demographic, socioeconomic, and medical risk factors for persistent OD are not well understood. This study aims to determine risk factors for development and persistence of OD amongst patients with COVID-19 infection.
Materials and methods: This prospective, observational questionnaire study was performed at a tertiary-level, academic center. Patients with history of a positive COVID-19 diagnosis were sent an online questionnaire. Patients' self-reported survey responses for OD and resolution were assessed for associations with demographic variables, socioeconomic factors, and clinical data.
Results: In total, 608 of 26,094 patients (77.6 % women, mean age 42.7 ± 17.4 years, range 9 months-92 years) completed the survey. OD was reported by 220 (36.2 %) patients, and 139 (63.2 %) patients achieved resolution. Patients with OD were more likely to have other sinonasal and flu-like symptoms, and had a hospitalization rate of 2.7 %. There were no significant differences in age, gender, occupational or residential factors, or medical comorbidities incidence of OD development. Women reported higher rates of persistent OD (88.9 % vs 77.0 %, p = 0.045). The OD recovery rates amongst active and resolved COVID-19 infections was 27.0 % and 70.0 %, respectively (p < 0.001).
Conclusions: There was a low hospitalization rate amongst patients reporting OD. One-third of patients with COVID-19 self-reported OD, and two-thirds of patients achieve OD resolution. Survey respondents with active COVID-19 infection and female gender were more likely to report persistent OD.
Keywords: Anosmia; COVID-19; Coronavirus-19; Dysgeusia; Olfactory dysfunction.
. 2023 Jun 21;44(5):103962.
doi: 10.1016/j.amjoto.2023.103962. Online ahead of print. Olfactory dysfunction incidence and resolution amongst 608 patients with COVID-19 infection
Shannon S Wu[SUP] 1 [/SUP], Claudia I Cabrera[SUP] 2 [/SUP], Humzah A Quereshy[SUP] 2 [/SUP], Arminé Kocharyan[SUP] 3 [/SUP], Brian D'Anza[SUP] 2 [/SUP], Todd Otteson[SUP] 4 [/SUP]
Affiliations
- PMID: 37356414
- DOI: 10.1016/j.amjoto.2023.103962
Purpose: Olfactory dysfunction (OD) is a common presenting sign of coronavirus-19 (COVID-19) infection and remains persistent in up to 7 % of patients one year after diagnosis. However, demographic, socioeconomic, and medical risk factors for persistent OD are not well understood. This study aims to determine risk factors for development and persistence of OD amongst patients with COVID-19 infection.
Materials and methods: This prospective, observational questionnaire study was performed at a tertiary-level, academic center. Patients with history of a positive COVID-19 diagnosis were sent an online questionnaire. Patients' self-reported survey responses for OD and resolution were assessed for associations with demographic variables, socioeconomic factors, and clinical data.
Results: In total, 608 of 26,094 patients (77.6 % women, mean age 42.7 ± 17.4 years, range 9 months-92 years) completed the survey. OD was reported by 220 (36.2 %) patients, and 139 (63.2 %) patients achieved resolution. Patients with OD were more likely to have other sinonasal and flu-like symptoms, and had a hospitalization rate of 2.7 %. There were no significant differences in age, gender, occupational or residential factors, or medical comorbidities incidence of OD development. Women reported higher rates of persistent OD (88.9 % vs 77.0 %, p = 0.045). The OD recovery rates amongst active and resolved COVID-19 infections was 27.0 % and 70.0 %, respectively (p < 0.001).
Conclusions: There was a low hospitalization rate amongst patients reporting OD. One-third of patients with COVID-19 self-reported OD, and two-thirds of patients achieve OD resolution. Survey respondents with active COVID-19 infection and female gender were more likely to report persistent OD.
Keywords: Anosmia; COVID-19; Coronavirus-19; Dysgeusia; Olfactory dysfunction.